Pedicled omental flaps  by Bonneton, G.
Eur J Vasc Endovasc Surg 12, 508-514 (1996) 
Correspondence 
Pedicled Omental Flaps 
Sir, 
I read with interest the article "Use of a Pedicled 
Omental Flap in the Treatment of an Infected Vascular 
Prosthetic Graft .1 The authors suggest that the 
presented case is to their knowledge the first report in 
literature. I am sorry to contradict them but my article 
describing a similar case was published 24 years ago 
in the journal Chirurgie. 2 1 am pleased to say that my 
patient remained free of recurrent infection with a 
patent graft during the 14 years following treatment 
by a pedicled omental flap. I have subsequently used 
this technique in four other cases with success in three 
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Arterial Graft Preservation 
Sir, 
I read with interest he paper by Vischjager et al. on 
arterial grafts preservation, 1 however I believe that 
some important information is lacking. 
The Authors correctly compare arterial with organ 
transplantation and state that the "gold standard" of 
organ preservation is presently cold storage in UW 
solution. This may be true for solid organs, but a wide 
body of literature demonstrates that long-term main- 
tenance of both morphological and physiological 
arterial characteristics is currently possible only with 
cryopreservation techniques, in the absence of data 
using other methods. 2 As stated by the authors, only 
short-term results of arterial preservation in UW 
solution are known; the results of a preservation 
interval of 14 days appear insufficient to draw 
conclusions on UW solution performance in creating a
bank of arteries. Moreover, functional response to 
contractile and relaxing agents showed a significant 
decrease over time, with a residual overall function of 
approximately 50% after 21 days and 0% after 60 
days. ~ These data argue against the possibility of 
extending UW solution preservation over 2 weeks. 
Since the Authors are currently studying the effects of 
longer storage intervals, it would have been more 
interesting to assess them all in a single paper, 
possibly with a comparison with cryopreserved 
specimens. 
The fate of morphologically preserved endothelial 
cells on the graft surface also remains obscure in the 
study. Although the morphological observations 
before and after arterial implantation suggest better 
preservation of endothelial cells in UW-preserved 
grafts, the actual behaviour of these cells under 
arterial flow conditions is not disclosed in the study. In 
fact, the Authors state that "... a neoendothelial layer 
had developed in the PBS groups (auto and allo 
PBS)...'. 1 Thus, the observation of good endothelial 
coverage in the implanted UW arteries is of little help 
in determining endothelial cell behaviour and viabil- 
ity. We have previously shown that morphologically 
intact, cryopreserved endothelial cells are not able to 
withstand arterial flow in the rabbit model, although 
complete re-endothelialisation occurs within few 
weeks. 3
Endothelial denudation occurs commonly even in 
freshly implanted human autologous veins, and the 
re-endothelialisation time is dependent on the amount 
of surgical damage. 4 It is known that endothelial 
coverage is easier in the animal model; therefore the 
data presented indicate only a different morphology 
of the endothelial layer in the treatment groups, and 
not necessarily the viability of the endothelial cells 
treated with UW solution. This issue is of paramount 
importance, since the benefit of preserving an intact 
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